Inagene Diagnostics Inc. provides personalized medicine with genetic guidance to medical cannabis users
November 18, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Since cannabis legalization in 2018, interest in its medical application has been skyrocketing. Canadian consumers and health care providers seek guidance...
Inagene Diagnostics Inc. and The Newly Institute partner to optimize treatment for Canadians living with pain and/or mental health conditions
November 16, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically...
Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians
November 01, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with fellow Canadian health-tech company, Granville Biomedical...
September’s International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain
August 26, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- September marks Canada’s most important International Pain Awareness Month yet. The stressors brought on by the COVID-19 pandemic have manifested as new...
Inagene and Aspiria team up to improve mental health care for post-secondary students
August 16, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with Student Assistance Program provider Aspiria Corp., a CloudMD...
Global Gene Panel Market to Surpass US$ 29,975.8 Million by 2028, Says Coherent Market Insights (CMI)
August 02, 2021 09:00 ET
|
CMI
SEATTLE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gene panel market is estimated to be valued at US$ 22,044.7 million in 2021 and is expected to exhibit a...
Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies
July 21, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic...
US & EU Direct-to-consumer Genetic Testing Market Report 2021
July 09, 2021 08:08 ET
|
Research and Markets
Dublin, July 09, 2021 (GLOBE NEWSWIRE) -- The "US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities" report has been added to ResearchAndMarkets.com's...
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing
June 08, 2021 07:00 ET
|
Inagene Diagnostics Inc.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Inagene Diagnostic Inc., a Canadian pharmacogenetic testing company, and Calian Group Ltd., one of Canada's largest national health services organizations,...
Worldwide Genomics in Cancer Care Industry to 2026 - Growing Burden of Cancer is Driving Growth
March 24, 2021 05:53 ET
|
Research and Markets
Dublin, March 24, 2021 (GLOBE NEWSWIRE) -- The "Genomics in Cancer Care Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...